Home | Business News | Browse by Publication | M | M2 Presswire

Applied NeuroSolutions, Inc. (OTCBB:APNS) just released some important news.

Article Excerpt
M2 PRESSWIRE-2 July 2008-Stockwire.com: Applied NeuroSolutions, Inc. (OTCBB:APNS) just released some important news.(C)1994-2008 M2 COMMUNICATIONS LTD

RDATE:02072008

Applied NeuroSolutions, Inc. (OTCBB:APNS) just announced Applied NeuroSolutions Achieves Q2 2008 Alzheimer's Disease Serum Diagnostic Development Program Milestone.

A dedicated Chat Room for Applied NeuroSolutions, Inc., has been created at STOCKWIRE.com to discuss this news event.

Visit the following link to begin chatting with your fellow shareholders: http://www.stockwire.com/chat

----------------------------------------------------------

Applied NeuroSolutions, Inc. (OTCBB:APNS) Tuesday July 1, 8:45 am ET

VERNON HILLS, Ill.-Applied NeuroSolutions, Inc. (OTCBB:APNS), a biotechnology Company focused on the development of products for the early diagnosis and treatment of Alzheimer's disease , recently announced the achievement of a key milestone directed to a multi-product program to develop serum-based diagnostic tests for Alzheimer's disease.

APNS has successfully achieved its Q2 milestone with the creation of proprietary tau based tools required for development of a serum-based test to support the diagnosis of AD. This builds on the company's Q1 2008 milestone in which tools were identified to support advancing their development of a diagnostic test to 'rule out' AD.

The Company's strategy to develop serum-based diagnostic tests includes identification of external resources that can leverage APNS's proprietary tools. APNS has identified specialized technology companies that meet the Company's criteria. As a next step, APNS will be collaborating with these companies to combine tools, technology and know how to focus on achievement of a Q4 2008 milestone to establish the feasibility of both a...